Tesseract Health
Molly Deacon has a diverse work experience in the field of clinical research. Molly is currently employed at Identifeye Health as a Clinical Program Manager since January 2023. Prior to this, Molly worked at Ora, Inc. as a Lead CRA from July 2021 to December 2022. Molly also served as a Senior Clinical Research Associate Lead at PSI CRO AG from September 2020 to July 2021, and as a Senior Clinical Research Associate at Premier Research from June 2019 to September 2020. Molly gained extensive experience at Syneos Health Clinical Solutions (Previously INC Research/inVentiv Health) where they worked as a Senior Clinical Research Associate from January 2017 to June 2019. Before that, Molly held roles at PRA Health Sciences as a Clinical Research Associate II from November 2013 to January 2017, and as an In House Clinical Research Associate II from December 2011 to November 2013. Molly began their career as a Senior Clinical Data Coordinator at Quintiles from August 2009 to December 2011. Molly's work experience started at the University of Nebraska Medical Center, where they worked as a Clinical Research Associate from June 2008 to August 2009.
Molly Deacon attended Nebraska Methodist College from 2002 to 2005, where they obtained a Bachelor of Science (BS) degree in Nursing.
This person is not in any offices
Tesseract Health
Tesseract is building a portable, affordable device for monitoring and preventing disease. Tesseract Health is part of the 4Catalyzer accelerator, with over $700 Million in funding, 300 scientists and engineers. Our offices are in Guilford CT, New York City, and Palo Alto. 4Catalyzer is founded by Jonathan Rothberg, the inventor of “Next-Gen” DNA sequencing and ultrasound-on-a-chip (Butterfly Network).